Expertise in
22
conditions

Dr. Arun Sanyal

Gastroenterology
Vcu Health West Hospital-Addiction Psychiatry And Consultation/Liaison Psychiatry
1200 E Broad St, 
Richmond, VA 
Offers Telehealth
39 Years of Experience
Expertise in
22
conditions
Vcu Health West Hospital-Addiction Psychiatry And Consultation/Liaison Psychiatry
1200 E Broad St, 
Richmond, VA 

Overview

Arun Sanyal is a Gastroenterologist practicing medicine in Richmond, Virginia. He has been practicing medicine for over 39 years.

Dr. Sanyal is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, Liver Transplant, and Endoscopy.

He is actively involved in clinical research, co-authoring 680 peer reviewed articles and participating in 20 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in VA

Hospital Affiliations

Medical College Of Virginia Hospitals

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthKeepers
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Vcu Health West Hospital-Addiction Psychiatry And Consultation/Liaison Psychiatry
1200 E Broad St, Richmond, VA 23298
Other Locations
Vcu Medical Center-Hume-Lee Transplant Center
1200 E Marshall St Fl 7, Richmond, VA 23298

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

20 Clinical Trials

Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
Vitamin E Dosing Study (VEDS): A Dose Finding Study of Vitamin E for the Treatment of Adult NAFLD
Enrollment Status: Completed
Publish Date: May 14, 2026
Intervention Type: Drug
Study Drug: Vitamin E
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control
A Prospective, Randomized, Double-Blind, Sham-Controlled, Multi-Center, Pivotal Study to Evaluate the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes With Inadequate Glycemic Control
Enrollment Status: Suspended
Publish Date: November 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
Enrollment Status: Completed
Publish Date: August 13, 2025
A Multicenter, Randomized, Double Blinded, Placebo-controlled Clinical Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis by the AlcHepNet Consortium
A Multicenter, Randomized, Double Blinded, Placebo-controlled Clinical Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis by the AlcHepNet Consortium
Enrollment Status: Completed
Publish Date: February 10, 2025
Intervention Type: Drug
Study Drugs: Anakinra and Zinc, Prednisone
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Rifaximin 550 Mg In Subjects With Severe Hepatic Impairment And Overt Hepatic Encephalopathy
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy, Safety, And Pharmacokinetics Of Rifaximin 550 Mg In Subjects With Severe Hepatic Impairment And Overt Hepatic Encephalopathy
Enrollment Status: Terminated
Publish Date: January 09, 2024
Intervention Type: Drug
Study Phase: Phase 4
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Randomized Master Protocol for Immune Modulators for Treating COVID-19
Enrollment Status: Completed
Publish Date: September 25, 2023
Intervention Type: Drug
Study Drugs: Infliximab, Abatacept, Remdesivir, Cenicriviroc
Study Phase: Phase 3
Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis
Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis
Enrollment Status: Completed
Publish Date: August 28, 2023
Intervention Type: Drug
Study Drugs: Vitamin C, Dextrose
Study Phase: Phase 2
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacodynamic Effects of MEDI0382 in Obese Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)/ Non-Alcoholic Steatohepatitis (NASH)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Pharmacodynamic Effects of MEDI0382 in Obese Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)/ Non-Alcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 17, 2023
Intervention Type: Drug
Study Drug: MEDI0382
Study Phase: Phase 2
View 9 Less Clinical Trials

679 Total Publications

Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary Fibrosis.
Cholangiocyte RUNX1 Orchestrates Fibrogenic and Inflammatory Signaling to Drive Biliary Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
Similar Doctors
Expertise in
21
conditions
Dr. Richard Sterling
Gastroenterology
Expertise in
21
conditions
Dr. Richard Sterling
Gastroenterology
Referral may be required

Virginia Commonwealth University Health System Authority

1250 E Marshall St, 
Richmond, VA 
 (0.1 miles away)
828-406-0804
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Richard Sterling is a Gastroenterologist practicing medicine in Richmond, Virginia. Dr. Sterling is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Liver Failure, Liver Transplant, and Kidney Transplant.

Expertise in
15
conditions
Dr. Jasmohan Bajaj
Gastroenterology
Expertise in
15
conditions
Dr. Jasmohan Bajaj
Gastroenterology
Referral may be required

Virginia Commonwealth University Health System Authority

1250 E Marshall St, 
Richmond, VA 
 (0.1 miles away)
804-828-8508
Languages Spoken:
English
See accepted insurances

Jasmohan Bajaj is a Gastroenterologist practicing medicine in Richmond, Virginia. Dr. Bajaj is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Liver Failure, Spontaneous Bacterial Peritonitis, Ascites, Liver Transplant, and Vagotomy.

Expertise in
25
conditions
Dr. Mohammad B. Siddiqui
Gastroenterology
Expertise in
25
conditions
Dr. Mohammad B. Siddiqui
Gastroenterology
Referral may be required

Gastrointestinal Specialists Inc

7611 Forest Avenue, Suite 320, 
Richmond, VA 
 (7.6 miles away)
804-285-8206
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mohammad Siddiqui is a Gastroenterologist practicing medicine in Richmond, Virginia. Dr. Siddiqui is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, Liver Transplant, and Endoscopy. Dr. Siddiqui is board certified in American Board Of Internal Medicine, (Internal Medicine, Gastroenterology), and (Internal Medicine).

Frequently Asked Questions about Dr. Arun Sanyal

How do I make an appointment with Dr. Arun Sanyal?

You can book an appointment with Dr. Arun Sanyal by calling their office at 804-828-4060. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Arun Sanyal a top-rated expert for Non-Alcoholic Fatty Liver Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Arun Sanyal is classified as an Elite expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Arun Sanyal specialize in?

While Dr. Arun Sanyal is a Gastroenterology, they have specific expertise in Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), and Cirrhosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Arun Sanyal participate in research or clinical trials?

Yes. Dr. Arun Sanyal has published 679 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Dr. Arun Sanyal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Arun Sanyal accept my insurance?

Dr. Arun Sanyal accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 804-828-4060 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sanyal's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 10 Advanced Conditions
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile